Rath T, Bokern E, Sefo-Bukow E, Büscher G, Lüngen M, Rubbert-Roth A
Institut für Gesundheitsökonomie und Klinische Epidemiologie, Universitätsklinik Köln, Gleueler Str. 176-178, 50935, Köln.
Z Rheumatol. 2011 Jan;70(1):56-63. doi: 10.1007/s00393-010-0703-4.
The choice between outpatient and inpatient care is currently undergoing major changes within the German health care system with the amendment of § 116b SGB V. This study investigates what proportion of hitherto inpatient rheumatologic care could potentially be given on an outpatient basis.
The analysis is based on administrative inpatient data from 2004 to 2008 covering approximately 23.6 million private health insurance insurants. The selection of patients with rheumatological diseases was based on diagnosis according to ICD-10 of § 116b SGB V.
From 2004 to 2008 the number of all rheumatologic cases increased by 13.9%, while the average length of hospital stay decreased from 9.46 days to 8.08 days and the number of attending hospitals declined by 3.1%. The number of rheumatologic cases with a short inpatient stay (≤2 days) increased by 32.3%. We define the ambulatory potential as the proportion of patients with a short length of stay to the total of inpatient rheumatologic cases; this increased from 25.7% to 29.9%.
Not all patients with a short inpatient stay can be transferred problem-free to ambulatory care. No channeling of patients to specialized centres has taken place thus far in Germany. Quality of care at the hospitals studied has not been considered. Further data are needed to link administrative data with quality care data.
随着德国社会法典第五编第116b条的修订,德国医疗体系中门诊治疗和住院治疗的选择目前正在经历重大变革。本研究调查了迄今为止住院风湿科治疗中可能转为门诊治疗的比例。
分析基于2004年至2008年的住院管理数据,涵盖约2360万份私人医疗保险参保者。风湿性疾病患者的选择基于德国社会法典第五编第116b条的ICD - 10诊断标准。
2004年至2008年,所有风湿病例数增加了13.9%,而平均住院天数从9.46天降至8.08天,就诊医院数量下降了3.1%。住院时间较短(≤2天)的风湿病例数增加了32.3%。我们将门诊治疗潜力定义为住院时间较短的患者占住院风湿病例总数的比例;这一比例从25.7%增至29.9%。
并非所有住院时间较短的患者都能顺利转为门诊治疗。德国目前尚未将患者分流至专科中心。本研究未考虑所研究医院的医疗质量。需要进一步的数据将管理数据与优质医疗数据联系起来。